Subject: Join your peers at the flagship iPSC event of the year!
Dear Colleague,
The spotlight is on iPSCs as the future of cell therapy after a flurry of recent industry news including Century Therapeutics’ first IND approval, CellOrigin and Qilu Pharma’s collaboration to produce off-the-shelf CAR-iMacrophage therapies, Cynata Therapeutics’ $1M government grant and most excitingly, the first implanted iPSC-derived patch for dAMD at the NIH.
To harness this excitement and potential the industry’s flagship iPSC-Derived Cell Therapies Summit is returning this December for the second year to reunite iPSC pioneers and provide a one-stop shop to overcome critical bottlenecks and produce safe, scalable and effective iPSC therapies.
Spanning discovery and translation to CMC and regulation, our two-stream agenda covers end-to-end iPSC development. Here’s a snapshot of the talks you could be missing:
- iPSC-Derived Blood Lineages for IO applications
George Daley, Dean of the Faculty of Medicine, Harvard Medical School - What Does the Perfect Value Chain Look Like to Develop iPSC Therapies?
Jacob Sten Petersen, Head of Cell Therapy Research & Development, Novo Nordisk - Boosting Genetic Engineering of iPSCs to Prevent Genetic Instability
Gregory Fiore, Chief Executive Officer, Exacis Biotherapeutics - Panel: Approaching Regulatory Affairs for iPSC-Derived Cell Therapies
Byeongtaek Oh, Associate Director, Regulatory Affairs, BlueRock Therapeutics
Luis Borlado, Head, Cell Therapy Product Development Research, Takeda
Jacob Sten Petersen, Head of Cell Therapy Research & Development, Novo Nordisk - Meet the industry’s leaders in our exclusive fireside chat: current learnings and the future’s outlook and developments
Cytovia Therapeutics, Century Therapeutics, Aspen Neuroscience, Exacis Biotherapeutics, Notch Therapeutics
View the full agenda and 30+ expert speakers here
Kind regards,
Isabella
P.S. If you book by this Friday, October 14, you could save $500 on your pass to the must-attend iPSC event of the year!
Isabella Maxton
Conference Producer– 2nd iPSC-Derived Cell Therapies Summit
Hanson Wade
Speakers – Event Guide – Register